B · Normal
[Sandoz plans to invest US$300 million to build a biosimilar API factory in Slovenia] On September 8, Sandoz announced that it plans to invest approximately US$300 million to build a new biosimilar API production facility in Ljubljana, Slovenia, which is expected to be put into production in 2029. The new facility will use disposable fed-batch (DFB) technology to add 8,000 liters of biopharmaceutical API production capacity through four reactors.
Global market intelligence 🕐 2026-09-08 13:20
#Global market intelligence
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

September 22nd, ADP data showed that in the four weeks ending September 5th, U.S 09-22 20:15 On September 22, the Kremlin stated that Putin had a phone call with the Saudi C 09-22 20:11 On September 22, B. Riley raised the target price of STRATEGY stock from $175 to 09-22 20:09 On September 22, the Baltic Dry Bulk Freight Index rose 0.97% to 3432 points. 09-22 20:03 September 22nd, ASML executives stated that Europe’s largest company (ASML) did 09-22 20:02 September 22nd, Accenture Edge cooperated with Amazon Cloud Technology (AWS) to 09-22 20:00

Comments

0/500
Captcha (click to refresh)
No comments yet